Winner Medical 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Jianquan Li

최고 경영자

CN¥3.1m

총 보상

CEO 급여 비율	n/a
CEO 임기	3.3yrs
CEO 소유권	n/a
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	3.3yrs

최근 관리 업데이트

Recent updates

Winner Medical Co., Ltd.'s (SZSE:300888) Shares Lagging The Industry But So Is The Business

Sep 16

Estimating The Fair Value Of Winner Medical Co., Ltd. (SZSE:300888)

Aug 19

Investors Could Be Concerned With Winner Medical's (SZSE:300888) Returns On Capital

Aug 02

Is Winner Medical (SZSE:300888) Using Too Much Debt?

Jul 15

Winner Medical (SZSE:300888) Will Pay A Smaller Dividend Than Last Year

May 31

There May Be Reason For Hope In Winner Medical's (SZSE:300888) Disappointing Earnings

May 01

There Are Reasons To Feel Uneasy About Winner Medical's (SZSE:300888) Returns On Capital

Apr 26

CEO

Jianquan Li (67 yo)

3.3yrs

테뉴어

CN¥3,073,400

보상

Mr. Jianquan Li is Chief Executive Officer of Winner Medical Co., Ltd. and serves as its Non-Independent Director since July 13, 2021. He also serves as Chairman of Winner Medical Co., Ltd.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Jianquan Li	CEO & Chairman	3.3yrs	CN¥3.07m	데이터 없음
Xiuyuan Fang	Non-Independent Director	3.3yrs	CN¥1.64m	0.020% CN¥ 3.9m
Xiaodan Xu	Non-Independent Director	3.3yrs	CN¥1.06m	0.0039% CN¥ 772.5k
Ke Liu Key	Independent Director	3.3yrs	CN¥180.00k	데이터 없음
Zhenwei Guo	Non-Independent Director	3.3yrs	데이터 없음	데이터 없음
Jianfeng Peng	Independent Director	3.3yrs	CN¥180.00k	데이터 없음
Jiawei Xie	Independent Director	3.3yrs	CN¥180.00k	데이터 없음
Tingting Zhang	Chairman of the Board of Supervisors	3.3yrs	데이터 없음	데이터 없음
Hua Liu	Employee Representative Supervisor	no data	데이터 없음	0.0038% CN¥ 744.9k
Zhifang Wang	Independent Director	less than a year	데이터 없음	데이터 없음
Junfa Chen	Independent Director	less than a year	데이터 없음	데이터 없음
Xiangliang Yang	Independent Director	less than a year	데이터 없음	데이터 없음

3.3yrs

평균 재임 기간

51yo

평균 연령

경험이 풍부한 이사회: 300888 의 이사회는 경험(평균 재직 기간 3.3 년)으로 간주됩니다.

Winner Medical 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

High number of new directors

Winner Medical Co., Ltd., Annual General Meeting, May 21, 2024

High number of new and inexperienced directors

High number of new and inexperienced directors

Winner Medical Co., Ltd., Annual General Meeting, May 13, 2022

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.29 (vs CN¥2.49 in 3Q 2023)

Now 21% overvalued after recent price rise

Investor sentiment deteriorates as stock falls 22%

Winner Medical Co., Ltd. to Report Q3, 2024 Results on Oct 29, 2024

Investor sentiment improves as stock rises 19%

Consensus EPS estimates increase by 13%

Winner Medical Co., Ltd. (SZSE:300888) acquired 75.2% stake in Global Resources International, Inc. for $120 million.

Winner Medical Co., Ltd. Announces Interim Cash Dividend of the Year 2024 of A Shares, Payable on 30 September 2024

Winner Medical Co., Ltd. Approves Interim Dividend for the Year 2024

Winner Medical Co., Ltd.'s (SZSE:300888) Shares Lagging The Industry But So Is The Business

Consensus EPS estimates fall by 14%

Second quarter 2024 earnings released: EPS: CN¥0.35 (vs CN¥0.52 in 2Q 2023)

High number of new directors

Estimating The Fair Value Of Winner Medical Co., Ltd. (SZSE:300888)

Investors Could Be Concerned With Winner Medical's (SZSE:300888) Returns On Capital

Is Winner Medical (SZSE:300888) Using Too Much Debt?

Winner Medical Co., Ltd. to Report First Half, 2024 Results on Aug 20, 2024

Winner Medical (SZSE:300888) Will Pay A Smaller Dividend Than Last Year

Dividend of CN¥0.50 announced

Winner Medical Co., Ltd. Announces Final Cash Dividend on A Shares for 2023, Payable on 04 June 2024

Price target decreased by 11% to CN¥37.77

Consensus EPS estimates fall by 20%

There May Be Reason For Hope In Winner Medical's (SZSE:300888) Disappointing Earnings

Winner Medical Co., Ltd. Proposes Final Cash Dividend for the Year 2023

There Are Reasons To Feel Uneasy About Winner Medical's (SZSE:300888) Returns On Capital

First quarter 2024 earnings released: EPS: CN¥0.31 (vs CN¥0.64 in 1Q 2023)

Winner Medical Co., Ltd., Annual General Meeting, May 21, 2024

Estimating The Fair Value Of Winner Medical Co., Ltd. (SZSE:300888)

Winner Medical Co., Ltd. to Report Q1, 2024 Results on Apr 25, 2024

Does Winner Medical (SZSE:300888) Have A Healthy Balance Sheet?

Now 21% overvalued

There's No Escaping Winner Medical Co., Ltd.'s (SZSE:300888) Muted Earnings

Investor sentiment improves as stock rises 24%

Now 26% overvalued

Winner Medical Co., Ltd. (SZSE:300888) announces an Equity Buyback for CNY 200 million worth of its shares.

Winner Medical Co., Ltd. to Report Fiscal Year 2023 Results on Apr 25, 2024

Price target decreased by 9.2% to CN¥50.82

Third quarter 2023 earnings released: EPS: CN¥2.49 (vs CN¥0.61 in 3Q 2022)

New major risk - Revenue and earnings growth

Winner Medical Co., Ltd. to Report Q3, 2023 Results on Oct 24, 2023

Consensus EPS estimates increase by 34%, revenue downgraded

Second quarter 2023 earnings released: EPS: CN¥0.52 (vs CN¥0.92 in 2Q 2022)

Winner Medical Co., Ltd. to Report First Half, 2023 Results on Aug 16, 2023

Consensus EPS estimates increase by 38%, revenue downgraded

Winner Medical Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 02 June 2023

Winner Medical Co., Ltd. Approves Cash Dividend for the Year 2022

Price target decreased by 9.3% to CN¥84.33

First quarter 2023 earnings released: EPS: CN¥0.89 (vs CN¥0.84 in 1Q 2022)

Now 20% undervalued after recent price drop

Now 20% undervalued

Price target increased to CN¥88.97

High number of new and inexperienced directors

Now 23% undervalued after recent price drop

Third quarter 2022 earnings released: EPS: CN¥0.85 (vs CN¥0.81 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥1.28 (vs CN¥0.66 in 2Q 2021)

Price target increased to CN¥84.00

Winner Medical Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2021, Payable on May 27, 2022

Winner Medical Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2021, Payable on May 27, 2022

Winner Medical Co., Ltd. Announces Dividend for 2021

Price target decreased to CN¥84.58

Consensus revenue estimates fall by 11%

First quarter 2022 earnings: EPS and revenues miss analyst expectations

High number of new and inexperienced directors

Winner Medical Co., Ltd., Annual General Meeting, May 13, 2022

Winner Medical Co., Ltd. Announces Final Dividend Proposal for 2021

Winner Medical Co., Ltd. (SZSE:300888) agreed to acquire 55% stake in Zhejiang Longtai Medical Technology Co., Ltd. from Wu Kangping, Huang Lepei and Wu Di for CNY 727.54 million.

Price target decreased to CN¥97.71

Winner Medical Receives U.S. FDA Market Access for the Silver Alginate Dressing

Investor sentiment deteriorated over the past week

Price target decreased to CN¥110